AMRN stock

Amarin Corporation PLC (AMRN) support and resistance · rev $87.3M

Amarin Corporation PLC (AMRN) is a drug manufacturers - general company listed on US.

This page maps Amarin Corporation PLC (AMRN) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported AMRN revenue for 2026-06-30 was $87.3M. Net income was -$18.2M. Revenue was up 93.5% from 2026-03-31 to 2026-06-30. AMRN currently screens at market cap $292.1M.

AMRN currently screens at market cap $292.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new AMRN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the AMRN quote page for the session range and the stock page for the full model.

Not investment advice.

Full AMRN analysis